Literature DB >> 1317125

Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats.

J Fox1, S Guan, A A Hymel, L G Navar.   

Abstract

This study was designed to improve and validate methods for the accurate and consistent quantitation of angiotensin (ANG) I and II levels in rat kidney and to determine the effects on renal ANG I and II of changes in dietary sodium intake and ANG-converting enzyme (ACE) inhibition. Kidneys from pentobarbital-anesthetized rats were rapidly removed and homogenized in methanol before extraction and purification of ANG peptides by solid-phase extraction and high-performance liquid chromatography (HPLC). Recoveries of 125I-ANG I and II were greater than 80%. Reversed-phase HPLC of the partially purified methanol extract showed that greater than 75% of the ANG I- and greater than 82% of the ANG II-like immunoreactivity coeluted with ANG I and II, respectively. Dietary sodium deprivation (0.003 meq/g) and excess (1.34 meq/g) for 7 days significantly (P less than 0.01) increased and decreased renal ANG I (296 +/- 30 and 82.6 +/- 15.8 vs. 161 +/- 18 fmol/g) and ANG II (216 +/- 16 and 45.6 +/- 11.8 vs. 98 +/- 16 fmol/g) contents, respectively. Plasma ANG I and II levels showed similar changes. ACE activity was significantly upregulated by sodium deprivation in both kidney (44% increase) and plasma (30% increase). In rats fed normal chow, infusion of enalaprilat for 1 h abolished plasma ACE activity but decreased renal ACE activity by only 58%. ACE inhibition increased renal and plasma ANG I levels 2.8- and 12-fold, respectively, and decreased renal and plasma ANG II levels 75-78%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317125     DOI: 10.1152/ajprenal.1992.262.5.F902

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Renal targeting of captopril selectively enhances the intrarenal over the systemic effects of ACE inhibition in rats.

Authors:  R Folgert G Haverdings; Marijke Haas; Gerjan Navis; Anne-Miek Van Loenen-Weemaes; Dirk K F Meijer; Dick De Zeeuw; Frits Moolenaar
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

2.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

3.  Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats.

Authors:  Weijian Shao; Dale M Seth; L Gabriel Navar
Journal:  Hypertension       Date:  2010-07-12       Impact factor: 10.190

Review 4.  Regulation of intrarenal angiotensin II in hypertension.

Authors:  L Gabriel Navar; Lisa M Harrison-Bernard; Akira Nishiyama; Hiroyuki Kobori
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

5.  Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.

Authors:  Dinko Susic; Edward D Frohlich; Hiroyuki Kobori; Weijian Shao; Dale Seth; L Gabriel Navar
Journal:  J Hypertens       Date:  2011-04       Impact factor: 4.844

6.  Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats.

Authors:  Nicolas Pelisch; Naohisa Hosomi; Masaki Ueno; Daisuke Nakano; Hirofumi Hitomi; Masaki Mogi; Kenji Shimada; Hiroyuki Kobori; Masatsugu Horiuchi; Haruhiko Sakamoto; Masayasu Matsumoto; Masakazu Kohno; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2010-12-16       Impact factor: 2.689

7.  Enhanced angiotensin-converting enzyme activity and systemic reactivity to angiotensin II in normotensive rats exposed to a high-sodium diet.

Authors:  Sandra Crestani; Arquimedes Gasparotto Júnior; Maria C A Marques; Jennifer C Sullivan; R Clinton Webb; J Eduardo da Silva-Santos
Journal:  Vascul Pharmacol       Date:  2013-12-07       Impact factor: 5.773

8.  Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension.

Authors:  Romer A Gonzalez-Villalobos; Ryousuke Satou; Dale M Seth; Laura C Semprun-Prieto; Akemi Katsurada; Hiroyuki Kobori; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

9.  Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system.

Authors:  Nicolas Pelisch; Naohisa Hosomi; Masaki Ueno; Hisashi Masugata; Koji Murao; Hirofumi Hitomi; Daisuke Nakano; Hiroyuki Kobori; Akira Nishiyama; Masakazu Kohno
Journal:  Hypertens Res       Date:  2009-11-27       Impact factor: 3.872

10.  Some effects of a low sodium diet high in potassium on the renin-angiotensin system and plasma electrolyte concentrations in normal dogs.

Authors:  H D Pedersen; J Koch; A L Jensen; K Poulsen; A Flagstad
Journal:  Acta Vet Scand       Date:  1994       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.